GRIFOLS | GRF - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Alcon AG USD 53M 1000K 2026-06
Amadeus IT EUR 20.3M 500K 2026-03
Amarin USD 3K 5K 2024-12
argenx SE USD 1000K 172K 2026-03
AstraZeneca USD 340M 144M 2026-06
Bayer EUR 675M 87M 2025-12
Demant DKK 424M 26M 2026-06
Ence Energia y Celulosa EUR 16.2M 7.1M 2025-12
Essilor EUR 168M 21M 2025-12
Fresenius EUR 81M 5M 2025-09
Fresenius Medical Care EUR 83M 4M 2026-06
Genmab DKK 139M 129M 2026-06
GlaxoSmithKline GBP 121M 46M 2026-06
GRIFOLS EUR 141.43M 61.28M 2025-06
Hikma Pharmaceutical USD 67M 47M 2025-12
Inditex EUR 35M 19M 2026-06
Lakefront Biotherapeutics EUR 1.72M 940K 2025-09
Merck EUR 137M 33M 2026-06
Novartis USD 462M 119M 2026-06
Philips EUR 83M 26M 2026-03
Roche Holding CHF 304M 7.5M 2025-06
Sanofi EUR 287M 109M 2026-06
Smith & Nephew USD 69M 1000K 2025-12
UCB EUR 49M 29M 2025-12
Viscofan EUR 2.65M 291K 2026-03